title: Significant developmental elevation in serum parathyroid hormone levels in a large kindred with familial benign (hypocalciuric) hypercalcemia.
abstract: OBJECTIVE
  A large kindred with familial benign hypercalcemia (FBH) is described because of the new observation of developmental increases in serum immunoreactive parathyroid hormone (iPTH) levels in affected individuals that lead to significantly elevated values in adults.
  
  
  METHODS
  After identification of the proposita, 46 kindred members spanning 5 generations, ages 1.5 to 91 years, were surveyed biochemically and/or studied by chart review. Two hypercalcemic adults underwent biopsy of the iliac crest following tetracycline labeling for histomorphometric study.
  
  
  RESULTS
  Of the 46 individuals studied, 19 were found to be affected. Serum iPTH levels, determined in three separate immunoassays, became supranormal by about age 30 years in the group of 15 hypercalcemic subjects examined biochemically and appeared to increase further thereafter. Serum alkaline phosphatase activity and creatinine levels were normal in these individuals, but inorganic phosphate levels were lower than in unaffected kindred members. Three of five affected adults older than age 40 years who were studied radiographically had changes suggestive of osteomalacia. Biopsy of the iliac crest of one of the subjects, a 51-year-old woman, confirmed the presence of defective skeletal mineralization.
  
  
  CONCLUSIONS
  In this kindred, FBH in adults can be especially difficult to distinguish from primary hyperparathyroidism because serum iPTH levels may be elevated. Furthermore, the disorder may not be totally benign. Osteomalacia, perhaps due to mild hypophosphatemia, can develop during adulthood. Review of data from other kindreds for evidence of developmental elevations in serum iPTH levels with careful search for skeletal disease in late adult life will help to clarify if we have observed an unusual variant of FBH.
authors.affiliation: Metabolic Research Unit, Shriners Hospital for Crippled Children, St. Louis, Missouri 63131.
authors.forename: C T
authors.initials: CT
authors.lastname: McMurtry
authors.forename: F W
authors.initials: FW
authors.lastname: Schranck
authors.forename: D A
authors.initials: DA
authors.lastname: Walkenhorst
authors.forename: W A
authors.initials: WA
authors.lastname: Murphy
authors.forename: D B
authors.initials: DB
authors.lastname: Kocher
authors.forename: S L
authors.initials: SL
authors.lastname: Teitelbaum
authors.forename: R C
authors.initials: RC
authors.lastname: Rupich
authors.forename: M P
authors.initials: MP
authors.lastname: Whyte
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000097:blood; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000097:blood* / Q000150:complications / Q000175:diagnosis / Q000235:genetics*; D007015:Hypophosphatemia, Familial / Q000150:complications; D007223:Infant; D008297:Male; D008875:Middle Aged; D010018:Osteomalacia / Q000000981:diagnostic imaging / Q000209:etiology; D010281:Parathyroid Hormone / Q000097:blood*; D010375:Pedigree; D011859:Radiography; D012044:Regression Analysis
chemical_list: D010281:Parathyroid Hormone